Sasha Damouni Ellis | executive |
Marianne De Backer | executive |
Phil Pang | executive |
Sung Lee | executive |
Huidong Wang | analyst |
Kyuwon Choi | analyst |
Patrick Trucchio | analyst |
Nik Gasic | analyst |
Eva Privitera | analyst |
Joseph Stringer | analyst |
Hello and welcome to Vir Biotechnology's Third Quarter 2023 Financial Results and Business Update Call. [Operator Instructions]I will now turn the call over to Sasha Damouni Ellis, Executive Vice President, Chief Corporate Affairs Officer.
You may begin, Ms. Damouni Ellis.
Thank you, and good afternoon.